Although there was no difference in the NR5A1 expression of adenomas and carcinomas in the cohort of patients <5 years of age, the subtraction expression level of TCF21-NR5A1 discriminates between benign and malignant tumors and may provide relevant information in addition to pathology analysis. Here, NR5A1 is linked to carcinoma.